Neuland Laboratories P/B Ratio
Neuland Laboratories (NEULANDLAB) P/B ratio is 16.3 (High), book value per share ₹1442.31 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Neuland Laboratories screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
NEULANDLAB P/B Ratio — Valuation Insights & Book Value Analysis
Neuland Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 16.3 (High). Explore NEULANDLAB true value to estimate fundamental worth using multiple valuation models.
- Stock appears overvalued with PB of 16.3, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 56.2% above historical average
- Trading at premium to sector average PB of -0.01
Neuland Laboratories P/B Ratio Historical Trend
NEULANDLAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read NEULANDLAB dividend growth for the complete payout history and dividend yield track record.
NEULANDLAB Historical P/B Ratio — Book Value Per Share & Year-End Price
Neuland Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 15.84 | ₹1442.31 | ₹22840.00 | ₹1,875 | High |
| 2025 | 12.94 | ₹1173.08 | ₹15175.00 | ₹1,525 | High |
| 2024 | 13.91 | ₹986.92 | ₹13723.80 | ₹1,283 | High |
| 2023 | 6.92 | ₹764.62 | ₹5291.40 | ₹994 | High |
| 2022 | 2.58 | ₹646.92 | ₹1666.95 | ₹841 | Moderate |
NEULANDLAB vs Healthcare Peers — P/B Ratio Comparison
Neuland Laboratories P/B 16.3 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |